Microenvironmental Control of the Breast Cancer Cell Cycle

Anatomical Record

Volumn 295, Issue 4, 2012, Pages 553-562

  Guo, Xun ^a,b   Wu, Yuehan ^c   Hathaway, Helen J ^a,b   Hartley, Rebecca S ^a,b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Cell cycle; Extracellular matrix; Mechano signaling; Microenvironment

Indexed keywords

COLLAGEN;

BASEMENT MEMBRANE; BIOCHEMISTRY; BREAST; BREAST CANCER; BREAST DEVELOPMENT; BREAST EPITHELIUM; CANCER INVASION; CARCINOGENICITY; CELL CYCLE PROGRESSION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MAMMARY GLAND; MAMMOGRAPHY; MICROENVIRONMENT; PRIORITY JOURNAL; REVIEW;

ANIMALS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84862796116     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22417     Document Type: Review

References (132)

1. Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, Mohsin SK, O'Connell P, Tsimelzon A, Medina D. 2008. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14: 370-378.
2. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. 2003. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 5: R129-R135.
3. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. 1996. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271: 20246-20249.
4. Assoian RK, Klein EA. 2008. Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol 18: 347-352.
5. Assoian RK, Schwartz MA. 2001. Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Curr Opin Genet Dev 11: 48-53.
6. Baker EA, Stephenson TJ, Reed MW, Brown NJ. 2002. Expression of proteinases and inhibitors in human breast cancer progression and survival. Mol Pathol 55: 300-304.
7. Bao G, Suresh S. 2003. Cell and molecular mechanics of biological materials. Nat Mater 2: 715-725.
8. Barbash O, Zamfirova P, Lin DI, Chen X, Yang K, Nakagawa H, Lu F, Rustgi AK, Diehl JA. 2008. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 14: 68-78.
9. Barsky SH, Rao CN, Grotendorst GR, Liotta LA. 1982. Increased content of Type V Collagen in desmoplasia of human breast carcinoma. Am J Pathol 108: 276-283.
10. Benaud CM, Dickson RB. 2001a. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Oncogene 20: 4554-4567.
11. Benaud CM, Dickson RB. 2001b. Regulation of the expression of c-Myc by beta1 integrins in epithelial cells. Oncogene 20: 759-768.
12. Berendsen AD, Bronckers AL, Smit TH, Walboomers XF, Everts V. 2006. Collagen type V enhances matrix contraction by human periodontal ligament fibroblasts seeded in three-dimensional collagen gels. Matrix Biol 25: 515-522.
13. Bissell MJ. 1981. The differentiated state of normal and malignant cells or how to define a "normal" cell in culture. Int Rev Cytol 70: 27-100.
14. Bissell MJ, Hall HG, Parry G. 1982. How does the extracellular matrix direct gene expression? J Theor Biol 99: 31-68.
15. Bissell MJ, Radisky D. 2001. Putting tumours in context. Nat Rev Cancer 1: 46-54.
16. Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. 2010. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 102: 1224-1237.
17. Boyd NF, Martin LJ, Rommens JM, Paterson AD, Minkin S, Yaffe MJ, Stone J, Hopper JL. 2009a. Mammographic density: a heritable risk factor for breast cancer. Methods Mol Biol 472: 343-360.
18. Boyd NF, Martin LJ, Stone J, Greenberg C, Minkin S, Yaffe MJ. 2001. Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention. Curr Oncol Rep 3: 314-321.
19. Boyd NF, Martin LJ, Yaffe M, Minkin S. 2009b. Mammographic density. Breast Cancer Res 11 Suppl 3: S4.
20. Breuls RG, Klumpers DD, Everts V, Smit TH. 2009. Collagen type V modulates fibroblast behavior dependent on substrate stiffness. Biochem Biophys Res Commun 380: 425-429.
21. Butcher DT, Alliston T, Weaver VM. 2009. A tense situation: forcing tumour progression. Nat Rev Cancer 9: 108-122.
22. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. 1995. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87: 1622-1629.
23. Caldon CE, Musgrove EA. 2010. Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer. Cell Div 5: 2.
24. Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM. 2002. The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol 161: 337-344.
25. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. 1997. Geometric control of cell life and death. Science 276: 1425-1428.
26. Chin K, de Solorzano CO, Knowles D, Jones A, Chou W, Rodriguez EG, Kuo WL, Ljung BM, Chew K, Myambo K, Miranda M, Krig S, Garbe J, Stampfer M, Yaswen P, Gray JW, Lockett SJ. 2004. In situ analyses of genome instability in breast cancer. Nat Genet 36: 984-988.
27. Cho MK, Suh SH, Lee CH, Kim SG. 2005. Bovine type I collagen inhibits Raw264.7 cell proliferation through phosphoinositide 3-kinase- and mitogen-activated protein kinase-dependent down-regulation of cyclins D1, A and B1. Biochim Biophys Acta 1744: 47-57.
28. Choquet D, Felsenfeld DP, Sheetz MP. 1997. Extracellular matrix rigidity causes strengthening of integrin-cytoskeleton linkages. Cell 88: 39-48.
29. Croft DR, Sahai E, Mavria G, Li S, Tsai J, Lee WM, Marshall CJ, Olson MF. 2004. Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res 64: 8994-9001.
30. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. 2002. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111: 29-40.
31. Discher DE, Janmey P, Wang YL. 2005. Tissue cells feel and respond to the stiffness of their substrate. Science 310: 1139-1143.
32. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N. 2000. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2: 252-257.
33. Emerman JT, Bartley JC, Bissell MJ. 1981. Glucose metabolite patterns as markers of functional differentiation in freshly isolated and cultured mouse mammary epithelial cells. Exp Cell Res 134: 241-250.
34. Faraldo MM, Deugnier MA, Lukashev M, Thiery JP, Glukhova MA. 1998. Perturbation of beta1-integrin function alters the development of murine mammary gland. EMBO J 17: 2139-2147.
35. Fata JE, Werb Z, Bissell MJ. 2004a. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 6: 1-11.
36. Fata JE, Werb Z, Bissell MJ. 2004b. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 6: 1-11.
37. Felsenfeld DP, Schwartzberg PL, Venegas A, Tse R, Sheetz MP. 1999. Selective regulation of integrin--cytoskeleton interactions by the tyrosine kinase Src. Nat Cell Biol 1: 200-206.
38. Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC. 2009. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 9: 20.
39. Frame MC. 2004. Newest findings on the oldest oncogene; how activated src does it. J Cell Sci 117: 989-998.
40. Fringer J, Grinnell F. 2001. Fibroblast quiescence in floating or released collagen matrices: contribution of the ERK signaling pathway and actin cytoskeletal organization. J Biol Chem 276: 31047-31052.
41. Fritz G, Just I, Kaina B. 1999. Rho GTPases are over-expressed in human tumors. Int J Cancer 81: 682-687.
42. Gehler S, Baldassarre M, Lad Y, Leight JL, Wozniak MA, Riching KM, Eliceiri KW, Weaver VM, Calderwood DA, Keely PJ. 2009. Filamin A-beta1 integrin complex tunes epithelial cell response to matrix tension. Mol Biol Cell 20: 3224-3238.
43. Giannone G, Jiang G, Sutton DH, Critchley DR, Sheetz MP. 2003. Talin1 is critical for force-dependent reinforcement of initial integrin-cytoskeleton bonds but not tyrosine kinase activation. J Cell Biol 163: 409-419.
44. Gill JK, Maskarinec G, Pagano I, Kolonel LN. 2006. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res 8: R30.
45. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF. 2001. Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 10: 243-248.
46. Hall HG, Bissell MJ. 1986. Characterization of the intermediate filament proteins of murine mammary gland epithelial cells. Response to collagen substratum. Exp Cell Res 162: 379-389.
47. Hall HG, Farson DA, Bissell MJ. 1982. Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc Natl Acad Sci USA 79: 4672-4676.
48. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100: 57-70.
49. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144: 646-674.
50. Henriet P, Zhong ZD, Brooks PC, Weinberg KI, DeClerck YA. 2000. Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. Proc Natl Acad Sci USA 97: 10026-10031.
51. Hood JD, Cheresh DA. 2002. Role of integrins in cell invasion and migration. Nat Rev Cancer 2: 91-100.
52. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. 2003. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114: 33-45.
53. Howlett AR, Bissell MJ. 1993. The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell Biol 2: 79-89.
54. Hu M, Polyak K. 2008. Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer 44: 2760-2765.
55. Hwang ES, DeVries S, Chew KL, Moore DH, 2nd, Kerlikowske K, Thor A, Ljung BM, Waldman FM. 2004. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin Cancer Res 10: 5160-5167.
56. Hynes RO. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687.
57. Jiang G, Giannone G, Critchley DR, Fukumoto E, Sheetz MP. 2003. Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin. Nature 424: 334-337.
58. Katsumi A, Naoe T, Matsushita T, Kaibuchi K, Schwartz MA. 2005. Integrin activation and matrix binding mediate cellular responses to mechanical stretch. J Biol Chem 280: 16546-16549.
59. Katsumi A, Orr AW, Tzima E, Schwartz MA. 2004. Integrins in mechanotransduction. J Biol Chem 279: 12001-12004.
60. Kenny PA, Bissell MJ. 2003. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer 107: 688-695.
61. Kim JH, Asthagiri AR. 2011. Matrix stiffening sensitizes epithelial cells to EGF and enables the loss of contact inhibition of proliferation. J Cell Sci 124: 1280-1287.
62. Kim JH, Kushiro K, Graham NA, Asthagiri AR. 2009. Tunable interplay between epidermal growth factor and cell-cell contact governs the spatial dynamics of epithelial growth. Proc Natl Acad Sci USA 106: 11149-11153.
63. Klein EA, Yin L, Kothapalli D, Castagnino P, Byfield FJ, Xu T, Levental I, Hawthorne E, Janmey PA, Assoian RK. 2009. Cell-cycle control by physiological matrix elasticity and in vivo tissue stiffening. Curr Biol 19: 1511-1518.
64. Klekotka PA, Santoro SA, Ho A, Dowdy SF, Zutter MM. 2001. Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. Am J Pathol 159: 983-992.
65. Klinowska TC, Soriano JV, Edwards GM, Oliver JM, Valentijn AJ, Montesano R, Streuli CH. 1999. Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse. Dev Biol 215: 13-32.
66. Kostic A, Sheetz MP. 2006. Fibronectin rigidity response through Fyn and p130Cas recruitment to the leading edge. Mol Biol Cell 17: 2684-2695.
67. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. 1996. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87: 1069-1078.
68. Le Beyec J, Xu R, Lee SY, Nelson CM, Rizki A, Alcaraz J, Bissell MJ. 2007. Cell shape regulates global histone acetylation in human mammary epithelial cells. Exp Cell Res 313: 3066-3075.
69. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM. 2009. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139: 891-906.
70. Li S, Butler P, Wang Y, Hu Y, Han DC, Usami S, Guan JL, Chien S. 2002. The role of the dynamics of focal adhesion kinase in the mechanotaxis of endothelial cells. Proc Natl Acad Sci USA 99: 3546-3551.
71. Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N. 2005a. The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14: 343-349.
72. Li N, Zhang Y, Naylor MJ, Schatzmann F, Maurer F, Wintermantel T, Schuetz G, Mueller U, Streuli CH, Hynes NE. 2005b. Beta1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoli. EMBO J 24: 1942-1953.
73. Liu Y, Chattopadhyay N, Qin S, Szekeres C, Vasylyeva T, Mahoney ZX, Taglienti M, Bates CM, Chapman HA, Miner JH, Kreidberg JA. 2009. Coordinate integrin and c-Met signaling regulate Wnt gene expression during epithelial morphogenesis. Development 136: 843-853.
74. Lu P, Ewald AJ, Martin GR, Werb Z. 2008. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol 321: 77-87.
75. Lyons TR, O'Brien J, Borges VF, Conklin MW, Keely PJ, Eliceiri KW, Marusyk A, Tan AC, Schedin P. 2011. Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med 17: 1109-1115.
76. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC. 2009. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 11: R7.
77. Maffini MV, Soto AM, Calabro JM, Ucci AA, Sonnenschein C. 2004. The stroma as a crucial target in rat mammary gland carcinogenesis. J Cell Sci 117: 1495-1502.
78. Martin LJ, Boyd NF. 2008. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10: 201.
79. McCormack VA, dos Santos Silva I. 2006. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 1159-1169.
80. Mercurio AM, Bachelder RE, Chung J, O'Connor KL, Rabinovitz I, Shaw LM, Tani T. 2001. Integrin laminin receptors and breast carcinoma progression. J Mammary Gland Biol Neoplasia 6: 299-309.
81. Muschler J, Streuli CH. 2010. Cell-matrix interactions in mammary gland development and breast cancer. Cold Spring Harb Perspect Biol 2: a003202.
82. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. 2011. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11: 558-572.
83. Naylor MJ, Li N, Cheung J, Lowe ET, Lambert E, Marlow R, Wang P, Schatzmann F, Wintermantel T, Schuetz G, Clarke AR, Mueller U, Hynes NE, Streuli CH. 2005. Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J Cell Biol 171: 717-728.
84. O'Brien J, Lyons T, Monks J, Lucia MS, Wilson RS, Hines L, Man YG, Borges V, Schedin P. 2010. Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol 176: 1241-1255.
85. Orimo A, Weinberg RA. 2006. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5: 1597-1601.
86. Page-McCaw A, Ewald AJ, Werb Z. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221-233.
87. Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, Bissell MJ. 2006. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res 66: 1526-1535.
88. Pasqualini R, Hemler ME. 1994. Contrasting roles for integrin beta 1 and beta 5 cytoplasmic domains in subcellular localization, cell proliferation, and cell migration. J Cell Biol 125: 447-460.
89. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM. 2005. Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241-254.
90. Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ. 1992. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89: 9064-9068.
91. Polyak K, Kalluri R. 2010. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol 2: a003244.
92. Pontano LL, Diehl JA. 2008. Speeding through cell cycle roadblocks: nuclear cyclin D1-dependent kinase and neoplastic transformation. Cell Div 3: 12.
93. Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. 2009. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 28: 4326-4343.
94. Provenzano PP, Keely PJ. 2009. The role of focal adhesion kinase in tumor initiation and progression. Cell Adh Migr 3: 347-350.
95. Provenzano PP, Keely PJ. 2011. Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling. J Cell Sci 124: 1195-1205.
96. Qian B, Deng Y, Im JH, Muschel RJ, Zou Y, Li J, Lang RA, Pollard JW. 2009. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 4: e6562.
97. Raub CB, Putnam AJ, Tromberg BJ, George SC. 2010. Predicting bulk mechanical properties of cellularized collagen gels using multiphoton microscopy. Acta Biomater 6: 4657-4665.
98. Raub CB, Unruh J, Suresh V, Krasieva T, Lindmo T, Gratton E, Tromberg BJ, George SC. 2008. Image correlation spectroscopy of multiphoton images correlates with collagen mechanical properties. Biophys J 94: 2361-2373.
99. Rizki A, Bissell MJ. 2004. Homeostasis in the breast: it takes a village. Cancer Cell 6: 1-2.
100. Roeder BA, Kokini K, Sturgis JE, Robinson JP, Voytik-Harbin SL. 2002. Tensile mechanical properties of three-dimensional type I collagen extracellular matrices with varied microstructure. J Biomech Eng 124: 214-222.
101. Rosenfeldt H, Grinnell F. 2000. Fibroblast quiescence and the disruption of ERK signaling in mechanically unloaded collagen matrices. J Biol Chem 275: 3088-3092.
102. Sawada Y, Tamada M, Dubin-Thaler BJ, Cherniavskaya O, Sakai R, Tanaka S, Sheetz MP. 2006. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 127: 1015-1026.
103. Schedin P, Keely PJ. 2011. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol 3: a003228.
104. Schedin P, Mitrenga T, McDaniel S, Kaeck M. 2004. Mammary ECM composition and function are altered by reproductive state. Mol Carcinog 41: 207-220.
105. Shekhar MP, Pauley R, Heppner G. 2003. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 5: 130-135.
106. Sherr CJ, Roberts JM. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18: 2699-2711.
107. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, Bell AK, Ferrier RK, Sandilands GP, Gusterson BA. 2004. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 6: R75-R91.
108. Streuli CH. 2009. Integrins and cell-fate determination. J Cell Sci 122: 171-177.
109. Streuli CH, Akhtar N. 2009. Signal co-operation between integrins and other receptor systems. Biochem J 418: 491-506.
110. Taddei I, Deugnier MA, Faraldo MM, Petit V, Bouvard D, Medina D, Fassler R, Thiery JP, Glukhova MA. 2008. Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol 10: 716-722.
111. Taddei I, Faraldo MM, Teuliere J, Deugnier MA, Thiery JP, Glukhova MA. 2003. Integrins in mammary gland development and differentiation of mammary epithelium. J Mammary Gland Biol Neoplasia 8: 383-394.
112. Trujillo KA, Heaphy CM, Mai M, Vargas KM, Jones AC, Vo P, Butler K, Joste N, Bisoffi M, Griffith JK. 2010. Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer 129: 1310-1321.
113. Tsuboi N, Yoshida H, Kawamura T, Furukawa Y, Hosoya T, Yamada H. 2000. Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells. Kidney Int 57: 1581-1589.
114. Wall SJ, Zhong ZD, DeClerck YA. 2007. The cyclin-dependent kinase inhibitors p15INK4B and p21CIP1 are critical regulators of fibrillar collagen-induced tumor cell cycle arrest. J Biol Chem 282: 24471-24476.
115. Wang HB, Dembo M, Hanks SK, Wang Y. 2001. Focal adhesion kinase is involved in mechanosensing during fibroblast migration. Proc Natl Acad Sci USA 98: 11295-11300.
116. Wang HB, Dembo M, Wang YL. 2000. Substrate flexibility regulates growth and apoptosis of normal but not transformed cells. Am J Physiol Cell Physiol 279: C1345-C1350.
117. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, Turley EA, Bissell MJ. 2002. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 94: 1494-1503.
118. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, Lupu R, Bissell MJ. 1998. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA 95: 14821-14826.
119. Weaver VM, Lelievre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, Werb Z, Bissell MJ. 2002. beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2: 205-216.
120. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. 1997a. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137: 231-245.
121. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. 1997b. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137: 231-245.
122. Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, Birk DE. 2004. Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem 279: 53331-53337.
123. White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, Muller WJ. 2004. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6: 159-170.
124. Willits RK, Skornia SL. 2004. Effect of collagen gel stiffness on neurite extension. J Biomater Sci Polym Ed 15: 1521-1531.
125. Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ, Soloway P, Itohara S, Werb Z. 2003. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 162: 1123-1133.
126. Wolf K, Friedl P. 2009. Mapping proteolytic cancer cell-extracellular matrix interfaces. Clin Exp Metastasis 26: 289-298.
127. Wozniak MA, Chen CS. 2009. Mechanotransduction in development: a growing role for contractility. Nat Rev Mol Cell Biol 10: 34-43.
128. Wozniak MA, Desai R, Solski PA, Der CJ, Keely PJ. 2003. ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol 163: 583-595.
129. Wu Y, Guo X, Brandt Y, Hathaway HJ, Hartley RS. 2011. Three-dimensional collagen represses cyclin E1 via beta1 integrin in invasive breast cancer cells. Breast Cancer Res Treat 127: 397-406.
130. Wyckoff JB, Pinner SE, Gschmeissner S, Condeelis JS, Sahai E. 2006. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 16: 1515-1523.
131. Yurchenco PD, Patton BL. 2009. Developmental and pathogenic mechanisms of basement membrane assembly. Curr Pharmaceutical Design 15: 1227-1294.
132. Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB, Allred C, Muthuswamy SK. 2008. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 135: 865-878.